Develops a revolutionary on-site diagnostic platform, using CRISPR-Cas’ inherent specificity and ease of use.
First name*
Organization type CorporateEducation/Research InstituteInvestor/FinancerOtherPress/MediaStartup/Scaleup
Email*
Get in touch
